Search the Newsreel

Why CCC Intelligent Solutions (CCC) Is Up 13.6% After Strong Q2 Results, Guidance And Buyback Completion

CCC Intelligent Solutions Holdings Inc. (CCC) saw its stock rise by 13.6% following strong second-quarter 2026 results, positive guidance for Q3 and the full year, and the completion of a significant share buyback program. The company's increased profitability and confident outlook reinforce its investment …

Lithium Argentina (LAR) Q2 Earnings Preview: Market Pricing High Growth Despite Unprofitability

CCOI INVESTOR DEADLINE: Cogent Communications Holdings Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit

Hagens Berman Sobol Shapiro LLP has filed a securities class action lawsuit against Cogent Communications Holdings (NASDAQ: CCOI) on behalf of investors who purchased stock between February 29, 2024, and May 1, 2026. The lawsuit alleges that Cogent misrepresented its growth prospects by touting …

Cogent Biosciences (NASDAQ:COGT) Shares Gap Down - Time to Sell?

Telecom Argentina: EBITDA margin, revenues, and free cash flow surged, driven by network expansion and ARPU growth

Telecom Argentina reported a significant increase in its EBITDA margin to 35.8% in the first half of 2026, with revenues climbing 23% year-over-year. This growth was fueled by strong service revenues, ARPU improvement, and accelerated network investments in 5G and FTTH. The company also …

Cogent Biosciences set to report earnings ahead of FDA decisions

Cogent Biosciences is scheduled to report second-quarter earnings, with investors keenly watching for updates on its commercial launch preparations for bezuclastinib, its lead drug candidate, ahead of potential FDA approvals later this year. The company is transitioning from a clinical-stage to a marketed-drug business …

Is Cogent Biosciences Inc (COGT) Worth the Risk After Q2 Earnings Miss? GF Score: 25/100

Don't Overlook Cogent (CCOI) International Revenue Trends While Assessing the Stock

Have you looked into how Cogent Communications (CCOI) performed internationally during the quarter ending June 2026? Considering the widespread global presence of this internet service provider, examining the trends in international revenues is essential for assessing its financial resilience and prospects for growth. The …

Cogent Biosciences (NASDAQ:COGT) Announces Earnings Results

Cogent Biosciences Q2 loss widens as bezuclastinib FDA deadlines approach

Cogent Biosciences (COGT) reported a widened net loss of $96.4 million in Q2 2026, up from $73.5 million in Q2 2025, driven by increased R&D and G&A expenses. The company has sufficient cash runway into late 2028 and is approaching key FDA PDUFA dates …

Discipline and Rules-Based Execution in FLGT Response

This article analyzes Fulgent Genetics Inc. (NASDAQ: FLGT), highlighting a near-term strong sentiment despite persistent mid and long-term weakness. It identifies a mid-channel oscillation pattern and an exceptional 98.2:1 risk-reward setup, targeting a 28.2% gain versus 0.3% risk. The article details three AI-generated trading …

Loma Negra (LOMA) Stock Could Be 49% Overvalued As Cash Flow Lags

Loma Negra (LOMA) has seen a strong 83.6% share price gain over the past five years, but its current price of US$10.44 suggests it is significantly overvalued. Both Discounted Cash Flow (DCF) analysis and P/E ratio comparisons indicate the stock trades at a premium, …

Cogent Biosciences (COGT) widens Q2 loss but nears FDA decisions on bezuclastinib

Cogent Biosciences reported a wider net loss of $96.4 million in Q2 2026, up from $73.5 million in Q2 2025, primarily due to increased R&D and G&A expenses. Despite this, the company is advancing towards potential FDA approvals for bezuclastinib in GIST (November 30, …

Cogent’s Bezuclastinib Could Reach FDA Decisions in Nov., Dec.

Cogent Biosciences reported its Q2 2026 financial results, highlighting significant progress for its drug bezuclastinib with FDA New Drug Applications submitted for GIST and systemic mastocytosis. The company anticipates FDA decisions for GIST by November 30, 2026, and for NonAdvSM by December 30, 2026. …

H.C. Wainwright cuts Emergent BioSolutions stock price target on revenue outlook

H.C. Wainwright has reduced its price target for Emergent BioSolutions (NYSE:EBS) to $10 from $12, while maintaining a Buy rating, due to a lowered full-year 2026 revenue guidance. The company's NARCAN sales have declined significantly due to new competition in the naloxone market, despite …

RBC ajusta su modelo para BBVA tras los resultados del segundo trimestre; mantiene la calificación de "Rendimiento en línea con el sector".

CCOI Q2 Deep Dive: Margin Expansion and Data Center Monetization Offset Revenue Decline

CCOI Q2 Deep Dive: Margin Expansion and Data Center Monetization Offset Revenue Decline Internet service provider Cogent Communications (NASDAQ:CCOI) fell short of the market's revenue expectations in Q2 CY2026, with sales falling 4.3% year on year to $235.6 million. Its non-GAAP loss of $0.45 …

Zhong An Intelligent Living Service Sets August Board Meeting for Interim Results and Dividend Review

Cogent Biosciences, Inc. $COGT Shares Sold by Hennion & Walsh Asset Management Inc.

Hennion & Walsh Asset Management Inc. significantly reduced its stake in Cogent Biosciences (NASDAQ:COGT) by 59.6% in the second quarter, selling 194,697 shares but retaining 131,775 shares valued at approximately $5.1 million. Despite this sale, analyst sentiment for Cogent Biosciences remains positive with a …

Cogent Communications Holdings, Inc. (NASDAQ:CCOI) Given Consensus Rating of "Hold" by Brokerages

Eleven research firms have issued a consensus "Hold" rating for Cogent Communications Holdings, Inc. (NASDAQ:CCOI), with an average 12-month price target of $23.10. While the company beat EPS estimates, its revenue declined year-over-year and analysts predict a full-year loss of $4.25 per share. The …

Fulgent Genetics, Inc. $FLGT Shares Sold by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP significantly reduced its stake in Fulgent Genetics (NASDAQ:FLGT) by 24.4% in the first quarter, selling over 217,000 shares. This comes as Fulgent Genetics reported a quarterly loss and revenue below analyst expectations, contributing to a "Hold" consensus rating among analysts. …

Banco Bbva Argentina SA (BBAR) Earnings Forecast: Future EPS & Revenue Growth Estimates

Telecom Argentina SA (TEO) Earnings Forecast: Future EPS & Revenue Growth Estimates

ROSEN, A RANKED AND LEADING FIRM, Encourages Cogent Communications Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CCOI

NEW YORK, Aug. 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cogent Communications Holdings, Inc. (NASDAQ: CCOI) between February 29, 2024 and May 1, 2026, inclusive (the “Class Period”), of the …

Versigent Q2 Earnings Call Highlights

Key Points Interested in Versigent? Here are five stocks we like better. Strong second-quarter performance: Net sales rose 11% year over year to $2.4 billion, while adjusted EBITDA increased 25% to $272 million and margins expanded to 11.1%. Versigent also secured more than $2.8 …

Bank of America Corp DE Purchases 324,678 Shares of CCC Intelligent Solutions Holdings Inc. Common Stock $CCC

Bank of America Corp DE has increased its stake in CCC Intelligent Solutions Holdings Inc. (NASDAQ:CCC) by 2.4%, acquiring an additional 324,678 shares. This purchase brings their total holdings to 14.0 million shares, valued at approximately $84 million. Other major institutional investors, including Wasatch …

Emergent BioSolutions Inc (EBS) Earnings Forecast: Future EPS & Revenue Growth Estimates

TD Cowen Maintains VERSIGENT PLC(VGNT.US) With Buy Rating, Raises Target Price to $58

TD Cowen has reiterated its Buy rating for VERSIGENT PLC (VGNT.US) and increased the target price to $58. This updated target price suggests a potential upside for the stock, reflecting the firm's positive outlook on the company's performance and prospects.

Telecom Argentina ADR earnings missed by $0.05, revenue fell short of estimates

Telecom Argentina ADR (NYSE: TEO) reported second-quarter EPS of $0.216, missing analyst estimates by $0.05, and revenue of $1.72 billion, falling short of the $1.73 billion consensus. Despite the miss, the company's stock has seen positive performance, rising 18.310% in the last three months …

Loma Negra Compania Industrial Argentina (NYSE:LOMA) Releases Earnings Results, Misses Expectations By $0.06 EPS

Telecom Argentina Stet - France Telecom (NYSE:TEO) Issues Earnings Results, Beats Expectations By $0.11 EPS

Telecom Argentina Stet - France Telecom (NYSE:TEO) reported quarterly earnings of $0.36 per share, exceeding analyst expectations by $0.11, with revenue matching estimates at $1.72 billion. Shares rose 0.3% to $13.85, and several analysts have upgraded the stock or raised price targets. Insider buying …

Telecom Argentina Swings to Profit and Lifts Investment on Strong 1H26 Results

Telecom Argentina reported strong first-half 2026 results, swinging to a consolidated net profit of P$869,038 million from a loss in the prior year, driven by foreign-exchange gains and consolidation of TMA. The company's revenues increased by 16.0% year-over-year, and it significantly boosted capital expenditure …

Intelligent Group Ltd (INTJ) Stock News Today

This article provides a brief overview of Intelligent Group Ltd (INTJ) stock news on TradingKey, noting that more news is expected soon. It includes current stock performance data, showing a 13.84% increase, and provides navigation to various financial and analytical sections for the company.

Loma Negra Compania Industrial Argentina Q2 Earnings Call Highlights

Key Points Interested in Loma Negra Compania Industrial Argentina S.A. Sponsored ADR? Here are five stocks we like better. Revenue grew despite weaker volumes: Second-quarter revenue rose 2.1% year over year to ARS 238.1 billion, supported by pricing, while cement volumes fell 1.4% but …

Cogent Communications Holdings, Inc. Securities Fraud Class Action Lawsuit Filed; September 21, 2026, Lead Plaintiff Deadline – Contact Kessler Topaz Meltzer & Check, LLP

Did you buy CCOI common stock between February 29, 2024 and May 1, 2026? Affected CCOI Investor Summary Who: Cogent Communications Holdings, Inc. (NASDAQ: CCOI)What: Securities fraud class action lawsuit filedClass Period: February 29, 2024 through May 1, 2026Deadline to Seek Lead Plaintiff Status: …

Gentex Plans Morocco Manufacturing Plant By 2028, Deepening Country’s Role As European Auto Supply Hub

Gentex Corp., a U.S.-based automotive technology supplier, plans to open a manufacturing facility in Morocco by 2028. This move aims to strengthen Morocco's role as a key automotive production hub and bring Gentex closer to its European customers. The investment reflects a growing trend …